The company was founded in May 1999 and listed on the Shenzhen Stock Exchange in June 2015. It is a national high-tech biomedical enterprise covering the fields of high-end preparations, biopharmaceuticals, modern traditional Chinese medicines, APIs, medical devices, biological breeding, etc. Our main business is the R&D, manufacture and sale of injectable injections. The company's main products are biological and biochemical drugs, covering the three major fields of use for cardiovascular diseases, immune diseases (anti-tumor), and neurological diseases. Company honors: Zhongguancun High-tech Enterprise, Beijing Patent Demonstration Unit, Capital Civilized Unit, Beijing Honest Creation Enterprise, etc.
No Data